Raoul S. Concepcion, MD, FACS

Raoul S. Concepcion, MD, FACS, director, Comprehensive Prostate Center, discusses current testing patterns in urology practices.

Raoul S. Concepcion, MD, FACS, discusses barriers to genetic testing for patients with prostate cancer as identified by community urologists.

My hopes were to be that rare individual who went through life never having to see the sharp end of a Bard-Parker scalpel. That fantasy is about to come to an abrupt end.

Over the past 5 years, the need for urologists to continue to be the leaders— the quarterbacks—in the diagnosis and management of prostate cancer has often been discussed. History will attest to urologists' success in leading this charge.

For the urologist who feels overworked and overstretched, paradigm-shifting advances may represent an opportunity to stave off burnout, more effectively use clinical acumen gained over the years, and maintain practice engagement.

Raoul S. Concepcion, MD, FACP, director, Comprehensive Prostate Center, discusses the potential for immunotherapy in the treatment of patients with castration-resistant prostate cancer.

It may take a restructuring of our current practice models, but we need to embrace, understand, and incorporate new technologies, both surgical and nonsurgical, to be at the forefront of precision medicine for our patients.

Raoul S. Concepcion, MD, FACS, discusses considerations for urologists in this new era.

Raoul S. Concepcion, MD, FACS, discusses the explosion of molecular testing in the urology world.

Raoul S. Concepcion, MD, FACS, discusses how to sort through the massive amount of data in the urology space, gain a basic understanding of its significance, and determine its clinical utility.

Raoul S. Concepcion, MD, FACS, discusses the importance of research opportunities for residents.

Raoul S. Concepcion, MD, FACS, discusses the current state of physicians the urology practice.

Prostate cancer continues to be the most common newly diagnosed solid tumor in men over 50 years and the second leading cause of cancerspecific mortality.

Because of vertical integration, this has allowed us to maintain economic stability in the face of diminishing reimbursement for professional services.

Over the past few decades, we have gradually ceded our diagnostic skills to technology.

Raoul S. Concepcion, MD, FACS, shares his insight on the evolving role of the clinical urologist.

The vision and dedication to training future urologic surgeons and advancing care by these giants of urology should never go unrecognized, underappreciated, or forgotten.

Raoul S. Concepcion, MD, discusses the new era of molecular testing and screening and how it has impacted the field of prostate cancer thus far.